These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 19142887)
1. Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms. De Boeck G; Forsyth RG; Praet M; Hogendoorn PC J Pathol; 2009 Feb; 217(3):327-44. PubMed ID: 19142887 [TBL] [Abstract][Full Text] [Related]
2. Protection against chromosome degradation at the telomeres. Grandin N; Charbonneau M Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802 [TBL] [Abstract][Full Text] [Related]
3. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Chan SW; Blackburn EH Oncogene; 2002 Jan; 21(4):553-63. PubMed ID: 11850780 [TBL] [Abstract][Full Text] [Related]
4. Telomere dysfunction in aging and cancer. Gilley D; Tanaka H; Herbert BS Int J Biochem Cell Biol; 2005 May; 37(5):1000-13. PubMed ID: 15743674 [TBL] [Abstract][Full Text] [Related]
5. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss. Arkus N J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310 [TBL] [Abstract][Full Text] [Related]
6. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process. Raynaud CM; Sabatier L; Philipot O; Olaussen KA; Soria JC Crit Rev Oncol Hematol; 2008 May; 66(2):99-117. PubMed ID: 18243729 [TBL] [Abstract][Full Text] [Related]
7. Give me a break: how telomeres suppress the DNA damage response. Denchi EL DNA Repair (Amst); 2009 Sep; 8(9):1118-26. PubMed ID: 19482563 [TBL] [Abstract][Full Text] [Related]
8. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes. Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260 [TBL] [Abstract][Full Text] [Related]
15. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer. Hsu CP; Ko JL; Shai SE; Lee LW Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636 [TBL] [Abstract][Full Text] [Related]
16. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres. Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006 [TBL] [Abstract][Full Text] [Related]
17. Targeting ALT: the role of alternative lengthening of telomeres in pathogenesis and prevention of cancer. Bollmann FM Cancer Treat Rev; 2007 Dec; 33(8):704-9. PubMed ID: 17933469 [TBL] [Abstract][Full Text] [Related]
18. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies. Fasching CL; Bower K; Reddel RR Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271 [TBL] [Abstract][Full Text] [Related]
19. Telomerase, senescence and ageing. Shawi M; Autexier C Mech Ageing Dev; 2008; 129(1-2):3-10. PubMed ID: 18215413 [TBL] [Abstract][Full Text] [Related]
20. Sizing the ends: normal length of human telomeres. Samassekou O; Gadji M; Drouin R; Yan J Ann Anat; 2010 Sep; 192(5):284-91. PubMed ID: 20732797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]